Company: SMNR
Filing Date: 2025-08-08
Form Type: S-4/A
Source: 0001193125-25-177097
Chunk: 638

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-08-08
Form: S-4/A
Chunk 638
---
 purchases shares of Denali Ordinary Shares (pre-Business Combination) or New Semnur Common Stock or New Semnur Series A Preferred Stock (post-Business Combination); (iii) that a maximum of 6,000,000 shares of New Semnur Series A Preferred Stock are issued in the Business Combination as Preferred Consideration; and (iv) that there will be an aggregate of 234,082,286 shares of New Semnur Common Stock issued and outstanding, which number of shares of New Semnur Common Stock is comprised of (a) the 2,572,500 Denali Ordinary Shares currently outstanding are exchanged for a corresponding number of shares of New Semnur Common Stock in connection with the Business Combination; (b) an aggregate of 200,600,000 shares of New Semnur Common Stock that are issued to Scilex and certain of its subsidiaries in the Business Combination; (c) 86,625 shares of New Semnur Common Stock issued to the Denali Underwriters pursuant to the Deferred Discount Agreement at Closing; (d) an aggregate of 30,500,000 shares of New Semnur Common Stock that are issued to consultants and services providers in the Business Combination pursuant to the terms of the Merger Agreement; and (e) that the Denali Promissory Notes are fully converted into 323,161 shares of New Semnur Common Stock in connection with Closing. |

388

|                                                                                                                          |     |                          |         |    |     |       |       |   |     |              |           |    |     |       |       |   |     |         |       |   |     | Post-Business Combination |             |     |     |       |       |   |     |              |           |     |       |     |   |     |         |       |   |     |                             |             |     |     |       |       |   |     |              |           |     |       |     |   |     |         |       |   |
|                                                                                                                          |     | Pre-Business Combination |         |    |     |       |       |   |     |              |           |    |     |       |       |   |     |         |       |   |     | Assuming No Redemptions   |             |     |     |       |       |   |     |              |           |     |       |     |   |     |         |       |   |     | Assuming